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SUMMARY
Using seven skin test antigens the cell-mediated immune response was evaluated
in 20 haemophiliacs, 10 human immunodeficiency virus (HIV) antibody-positive
and 10antibody-negative. Response rates were compared with 75 healthy males
ofsimilar age range. All haemophiliac patients displayed significant impairment
ofcell-mediated reactivity to the test antigens; however, there was no apparent
correlation with HIV antibody status.
INTRODUCTION
The acquired immune deficiency syndrome (AIDS) results from destruction of a
subset of cells (helper T-cells) which regulate the cell -mediated immune system.
The causative agent was found to be an RNA retrovirus designated human
immunodeficiency virus (HIV). Infection with this agent may result in only partial
damage of the immune system and patients may, therefore, remain completely
asympotamic. However, approximately 30% eventually develop the complete
immunodeficiency syndrome. While virtually all subjects (>95 %) who have
encountered the virus develop antibodies and became HIV antibody-positive,
there are as yet no methods of predicting which individuals will progress to the
state of profound immunodeficiency.
Before the causative agent of AIDS was discovered, infective blood products
were accidentally used to treat patients with bleeding disorders, including
haemophilia, and many haemophiliacs are now HIV antibody -positive.I
We studied these patients to determine whether in vivo testing of the cell -
mediated immune system could identify those who had been exposed to the HIV
agent. Some workers have shown that haemophiliacs, whether HIV antibody-
positive or -negative, exhibit impaired cell -mediated immune response to a
specific challenge with a single antigen not previously encountered,2 although
this type of testing has a number of disadvantages.3 Assessment of in vivo
reactivityofthe cell-mediated immune system tomultiple antigens, using delayed
cutaneous hypersensitivity (DCH), overcomes many ofthese disadvantages4 and
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also provides information regarding the recall of immune response to antigens
previously encountered by individuals as a result of infection and/or vaccination
programmes. The Multitest CMI system5 was used to study 20 haemophiliac
patients, 10 of whom were HIV antibody -positive and 10 antibody negative and
75 healthy males of similar age range.
MATERIALS AND METHODS
Study population
Twenty haemophiliac patients, age range 19 - 64 years (mean 31 years) were
tested using the Multitest CMI system. Nineteen patients were suffering from
Haemophilia A, while one patient had Haemophilia B (Christmas disease). All
patients were asymptomatic at the time of study with none displaying any clinical
evidenceof immunodeficiency. The testing wasperformed by asingle investigator
(RA Mcl) to avoid observer error; the HIV antibody status and T lymphocyte
subsets results were determined independently. Results were compared with 75
healthy males, age range 19-65 years (mean 36 years) who were randomly
selected from the general population. Persons with concurrent or recent illness
were excluded aswere any subjects taking drug therapy known to cause immuno -
suppression. Written informed consent was obtained from all subjects.
Multitest CMI and scoring system
The test system consists of a plastic disposable multiple puncture device capable
of simultaneously applying eight test materials.5 The antigens are applied by two
rowsoffour puncture heads. The heads are 20mm apart sothat positive reactions
do not interfere with each other. Application was made to the volar surface of
the forearm and skin induration was measured at 48 hours. The size of the
inflammatory response was taken as the average of measurements made in two
perpendicular directions. Reactions were considered positive if > 2mm. The test
materials include seven delayed type hypersensitivity antigens and a glycerin/
saline diluent (negative control). The antigens used were two toxoids, tetanus and
diphtheria, three bacterial antigens, Streptococcus, Tuberculin and Proteus, and
two fungal antigens, Candida and Trichophyton.6
The scoring system which was used reflected the overall DCH reactivity of an
individual. The score consisted of two parts: the first was the sum of the average
millimetre induration for all positive responses; the second was the number of
positive antigen responses out of the possible seven.
T lymphocyte subsets
At the time of the multitest CMI testing, blood was withdrawn to enumerate the
proportion and absolute numbers of T lymphocyte subsets in all haemophiliac
subjects. Mononuclear cells were separated by Ficoll hypaque density gradient
centrifugation and thecells identified byan indirect immunofluorescent technique
using monoclonal antibodies to OKT3, OKT4 and OKT8 phenotype markers for
pan -T cells, helper -inducer and suppressor cytotoxic subsets respectively.
HIVantibody status
Blood was withdrawn and the presence of antibodies to the HIV virus was
determined using an enzyme-linked immunosorbent assay (ORGANON).
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Statistical analysis to DATA
The Mann Whitney U test was used to compare the frequency of positive
reactions for each ofthe seven test antigens andthe total millimetres of induration
for each individual.
RESULTS
For the control population, the total inflammatory response ranged from
0-33mm with a median of 15mm. In haemophiliac patients, the range was
0- 14mm with a median of 3mm. This was statistically significant at the 0.1 %
level. The number of positive responses to the antigens tested also showed a
significant reduction in the haemophiliacs with a median value of 2 in this group
compared with 3 for the control population; this again was significant at the
0.1 % level. Overall, 99% of normal individuals reacted to one or more of the
test antigens compared with 75% of the haemophiliacs, while positive reactions
to two or more antigens were found in 95% and 50% respectively (Table 1).
TABLE I
Number ofcontrol subjects and haemophiliacs with positive responses to
test antigens
No. of
positive reactions 75 Controls 20 Haemophiliacs
0 1 ( 1 %) 5 (25%)
. 1 74 (99%) 15 (75%)
. 2 71 (95%) 10 (50%)
. 3 57 (76%) 4 (20%)
.4 35 (47%) 1 (5%)
.5 18 (24%) 1 (5%)
.6 4(5%) 0
. 7 1 ( 1%) 0
Only one of the 75 normal individuals failed to respond to any of the antigens
(1.3%) while five of the 20 haemophiliacs (25%) were completely anergic.
However, analysis of data comparing haemophiliacs who are HIV antibody-
positive with those HIV antibody-negative showed no statistical difference for
either total inflammatory response or number of positive responses. Analysis of
the data for reactivity towards individual test antigens showed a marked
impairment of response towards the tuberculin reagent in the haemophiliac
population with only one of the 20 showing a positive response compared with
58 ofthe 75 normal subjects (Table I1). The mean numberofhelperT-cells in the
patients positive for antibody to HIV was 675 (range 410-1180) cells/mm3
compared with a mean value of 725 (range 410- 1010) cells/mm3 in the HIV
antibody-negative patients. This difference was not statistically significant.
All the haemophilia A patients had received cryoprecipitate and Factor VIII
concentrate. The meanquantity used perpatientwas51,439 units. Nocorrelation
was found between the quantity of blood product given and HIV status or degree
of suppression of the cell-mediated immune response. The patient who had
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received the maximum quantity of Factor VIII (347,000 units) was HIV-negative
with normal CMI response, while the patient with haemophilia B had received no
Factor Vill or cryoprecipitate but became HIV-positive after plasma infusion.
TABLE II
Number of control subjects and haemophiliacs with positive DCH responses to
test antigens
Test antigen 75 Controls 20 Haemophiliacs
Tuberculin 58 (77%) 1 ( 5%)
Candida 56 (75%) 13 (65%)
Tetanus 51 (68%) 10 (50%)
Diphtheria 37 (49%) 4 (20%)
Proteus 27 (36%) 0
Streptococcus 23 (31 %) 3 (15%)
Tricophyton 10 (13%) 0
DISCUSSION
The Multitest CMI system evaluates the competence of the cellular immune
system in vivo, and in particular its ability to respond to antigens previously
encountered by the individual. Our results show that all haemophiliac patients
treated with blood Factor VIII concentrates have significantly impaired responses
compared with a healthy age/sex matched population. Nosignificantly detectable
difference in the responses of haemophiliacs HIV antibody- positive or HIV
antibody-negative could be shown and, therefore, this method of testing would
not be helpful in screening haemophiliacs for possible previous exposure to the
AIDS virus. There was no apparent correlation between reduced cell-mediated
immune response and quantity of Factor Vill used or the presence or absence of
inhibitors.
This study would confirm the findings of other workers,' that haemophiliac
patients display impaired cell-mediated immunity. While Madhok et al2 have
recently shown this phenomenon using a single test antigen (DNCB), our data
would indicate that, despite presumably similar exposure to infectious agents
and vaccination programmes, haemophiliacs become anergic to previously
encountered antigens or fail to develop normal recall for antigens to which they
have been exposed. The lack of correlation between depressed reactivity and HIV
antibody status or quantity of Factor Vill treatment would suggest that the state
of impaired reactivity may not be iatrogenic, but rather an inherent defect in
haemophiliacs. However, it may indicate exposure of these patients to immuno -
suppressive agents other than HIV. While our study shows that haemophiliac
patients fail to react positively to the tuberculin antigen, the clinical significance
remains unclear. These patients were not discouraged from receiving BCG
vaccination and we know of no increased incidence of tuberculosis in haemo-
philiacs compared with the general population.
We wish to acknowledge the help of Dr J Connolly who performed the HIV antibody testing.
© The Ulster Medical Society, 1987.
98Immune response in haemophiliacs 99
REFERENCES
1. Froebel KS, Madhok R, Forbes CD, et al. Immunological abnormalities in haemophilia: are they
caused by imported American Factor Vil concentrate? Br Med J 1983; 287: 1091-3.
2. Madhok R, Gracie A, Lowe GDO, et al. Impaired cell-mediated immunity in haemophilia in the
absence of infection with human immunodeficiency virus. Br Med J 1986; 293: 978-80.
3. Bates SE, Suent JY, Tranum BL. Immunological skin testing and interpretation. A plea for
uniformity. Cancer 1979; 43: 2306-14.
4. Maxwell AP, McCluskey DR. Assessment of cell-mediated immunity in a British population using
multiple skin test antigens. Clin Allergy 1986; 16: 365-9.
5. Kniker WT, Anderson CT, Roumiantzeff M. Measurement of delayed cutaneous hypersensitivity
(DCH) in healthy adults by Multitest (MT) system. Allergol Immunopathol 1980; 8: 267-71.
6. Kniker WT, Anderson CT, McBryde JL, Roumiantzeff M, Lesourd B. Multitest CMI for
standardised measurement of delayed cutaneous hypersensitivity and cell-mediated immunity.
Normal values and proposed scoring system for healthy adults in the U.S.A. Ann Allerg 1984;
52: 75-82.
) The Ulster Medical Society, 1987.